Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
about
Exploiting Literature-derived Knowledge and Semantics to Identify Potential Prostate Cancer DrugsAltered radiation fractionation schedules for clinically localised and locally advanced prostate cancerMortality results from a randomized prostate-cancer screening trialSystematic Review of Focal Prostate Brachytherapy and the Future Implementation of Image-Guided Prostate HDR Brachytherapy Using MR-Ultrasound Fusion.Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysisPharmacologic and surgical therapies for sexual dysfunction in male cancer survivorsOptimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk nonmetastatic prostate cancer: A systematic review and metaanalysisInfluence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapyQuality of life and satisfaction with information after radical prostatectomy, radical external beam radiotherapy and postoperative radiotherapy: a long-term follow-up study.Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.Lack of comprehension of common prostate cancer terms in an underserved population.Coagulation of human prostate volumes with MRI-controlled transurethral ultrasound therapy: results in gel phantoms.A preliminary exploration of the feasibility of offering men information about potential prostate cancer treatment options before they know their biopsy resultsLong-term functional outcomes after treatment for localized prostate cancer.Bayesian latent-class mixed-effect hybrid models for dyadic longitudinal data with non-ignorable dropouts.The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trialData pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancer.Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysisFactors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)Simulation study on the heating of the surrounding anatomy during transurethral ultrasound prostate therapy: a 3D theoretical analysis of patient safety.Prostate cancer outcomes in France: treatments, adverse effects and two-year mortalityDisclosure of diagnosis and treatment among early stage prostate cancer survivors.State-level cancer quality assessment and research: building and sustaining the data infrastructure.Management of complications of prostate cancer treatment.Physician social networks and variation in rates of complications after radical prostatectomy.Principles of cancer screening: lessons from history and study design issues.Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and ProgressionEarly experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment.Updated counselling for the patient with prostate cancer.Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer.Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.Novel diagnostic biomarkers for prostate cancer.Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.Quality-of-life effects of prostate-specific antigen screening.Prostate cancer in young men: an important clinical entity.Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.MR thermometry in the human prostate gland at 3.0T for transurethral ultrasound therapyBone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study.The Japanese guideline for prostate cancer screening.
P2860
Q22122725-CFD2C7B8-E1E5-4FE3-A0D8-7DB8335284BBQ24186971-C47AEC0A-1A6F-4FFC-8F0E-3357F24F94E8Q24601536-7B8ADC1E-0F29-4BC5-8F40-19FB905EB9DCQ26746913-3AFF63BE-64DB-4B6F-B868-C20DC1DC0956Q26764960-AE328249-0214-4B77-8F13-BFFE671737A1Q26773724-E4D40362-40C2-4599-A362-6C678E2386BDQ26801000-4A603156-2129-4DFF-9C8A-BC5843C39C5AQ27308917-479C2675-1192-473D-AFBA-3146A822F47DQ30209897-497B78F2-6A48-4595-B15A-C255B9E67689Q30252065-1828BB63-1244-4EB7-9270-5D0285423D45Q30436410-883BE8B2-D438-488A-8A08-5987F37D6BC8Q30452994-4C2CF3BC-6A62-4C44-80E6-E566AF0C0118Q30537734-72599E2A-8FC4-46B3-8029-3460BF4CD7BFQ30542816-36957598-3599-447C-9D9F-955A56760FD3Q30575084-66C5C432-CE43-4C2C-8DB5-E800CC679A92Q30641961-96C294E0-50E6-42F9-A834-FA22B5363899Q30845863-091E5B03-7E88-40BF-8E7D-1E014FE0AB8FQ30988028-926C83B7-01C7-4AAE-BA82-F6BD995C025DQ31143305-2B95B123-9A95-45D0-9F7B-CD0ACCFB50A7Q33559123-6A28A84D-B422-4C48-AE72-46C2525001DCQ33633253-F54956D6-9D00-4E10-9BC7-108C15D698E7Q33795089-5803EE01-D6B1-43E9-89EE-FD398EA48B42Q33798557-FD3AC897-CD4C-4F7C-A8C0-76C15008A7DEQ33974816-BFD809F6-D031-4974-AA38-1D50E7D46639Q33978360-A17257F3-4121-4FED-A413-6B9EC8BF3B62Q34055665-4185AF7E-9559-465A-A557-F4DDA8E99A70Q34065705-D0B97B13-3DD9-4D3A-BBC2-BB7B14DC0773Q34090617-CF4715A7-184A-4ED3-8C36-1B3C4ADB42EDQ34107347-D420AB1A-6765-4886-95AA-98E6994BAE27Q34108870-0B1C47AF-AF58-4018-BF11-E8A290FC7066Q34151889-4D73B7AD-C92F-4C32-B49F-A1E42524A8A7Q34197475-51456E05-9E7C-46F5-9E05-454B3D9D4FDAQ34231678-18B83517-CC8B-4069-9D83-D6A322189BADQ34268907-A2DAB934-5B0B-43DF-B4C0-89CCEF94F86EQ34294102-5A6E34FD-C2F2-4D78-91B4-2DE017454E03Q34314644-075BB770-E27D-4EDA-AFF3-807CA178FF1CQ34315605-C1BEE1BF-C0F1-4ADE-8935-63BE7195680EQ34323815-DD69E1AF-F204-4C29-B6AB-1C3F45A7A9A1Q34490592-1701CD4F-F41E-461C-A53F-6DCBA0079282Q34606240-D2477987-0C9F-430F-BDFD-7F10280838F5
P2860
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Five-year outcomes after prost ...... rostate cancer outcomes study.
@en
Five-year outcomes after prost ...... rostate cancer outcomes study.
@nl
type
label
Five-year outcomes after prost ...... rostate cancer outcomes study.
@en
Five-year outcomes after prost ...... rostate cancer outcomes study.
@nl
prefLabel
Five-year outcomes after prost ...... rostate cancer outcomes study.
@en
Five-year outcomes after prost ...... rostate cancer outcomes study.
@nl
P2093
P2860
P356
P1476
Five-year outcomes after prost ...... rostate cancer outcomes study.
@en
P2093
Arnold L Potosky
Janet L Stanford
Linda C Harlan
Robert A Stephenson
William W Davis
P2860
P304
P356
10.1093/JNCI/DJH259
P407
P577
2004-09-01T00:00:00Z